Search

ALL PSYCHEDELIC AND PSYCHEDELIC STOCK NEWS

Interview: Dr. Deborah Nash, Ibogaine and Miami Based DemeRX.

INTERVIEW Editor | Curator -
Partnered with ATAI Life Sciences ATAI. Amazing Interview. "I said there's no way that you can take one dose of Ibogaine...
View Post

Psychedelic Marketing: Adrian Morrison

Uncategorized Editor | Curator -
https://youtu.be/EZPAoTFqaro
View Post

Shark Tank’s Kevin Harrington Invests In Psychedelics Company Psycheceutical (BWVI). Forbes

2023 Watch List Editor | Curator -
Mike Zapolin, Kevein Harrington and CEO Chad Harman Another Shark Tank original has invested in the psychedelic industry.
View Post

Adding Psycheceutical Bioscience (BWVI) $0.14 to Watch List. (Ketamine.)

2023 Watch List Editor | Curator -
Above: Lamar Odom and Psychedelic Advocate Mike Zappy Zapolin. We’re Calling a Sector Bottom, and Psycheceutical (BWVI)...
View Post

Ketamine and Yale University

INTERVIEW Editor | Curator -
Depression is one of the most common and most debilitating mental health disorders, affecting some 17 million adults in the US. It...
View Post

Johns Hopkins Receives $20M From Roland R. Griffiths Ph.D. Professorship Fund For Psychedelic Research

CLINICAL TRIALS Editor | Curator -
John Hopkins Center for Psychedelic and Consciousness Research Johns Hopkins University academics just a got a boost in their funding thanks to...
View Post

Is ATAI Live Sciences (ATAI) $2.00, Finally Turning?

2023 Watch List Editor | Curator -
After Dropping 94% From Post IPO high from $19.45, a loss of exceeding $3 billion and change, ATAI is in the early...
View Post

PSYCHECEUTICAL TO CONDUCT THE FIRST EVER PHASE I AND II CLINICAL TRIALS OF A NOVEL KETAMINE TOPICAL CREAM TO TREAT PTSD

INTERVIEW Editor | Curator -
Psycheceutical ​​enters into agreement with iNGENū to conduct ​human ​clinical trials of NeuroDirect™ ketamine topical ​in Australia
View Post

The Kahner Global Cannabis & Psychedelics Investment Summit.

PSYCH NEWS Editor | Curator -
Kahner Global’s 8th annual Cannabis & Psychedelics Investment Summit  When:...
View Post

Awakn Life Sciences (AWKNF) $0.30 Announces Signing of Lease for Second Clinic in Norway.

CLINICS Editor | Curator -
Trondheim in central Norway will be the location of Awakn's 4th clinic LIVE QUOTE
View Post

Silo Pharma (SILO) Issues Letter to Shareholders

2023 Watch List Editor | Curator -
Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine LIVE QUOTE
View Post

Silo Pharma (SILO) $3.36 Achieves New Milestone for SP-26 Therapeutic -Initiates IND Enabling Study of Topical Ketamine Formulation

Featured Editor | Curator -
View Post ENGLEWOOD CLIFFS, NJ, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage...
View Post

Stressed Wall Street Execs Flock to Ketamine Therapy Sessions (NY Post)

CLINICS Editor | Curator -
Therapy’s a trip for these Wall Street executives. Wealthy stock traders are flocking to a Manhattan-based ketamine therapy practice that doles out...
View Post
123...9Page 1 of 9

KetaDash

Ketamine at Home Treatments
RESEARCH

Most Popular

Interview: Dr. Deborah Nash, Ibogaine and Miami Based DemeRX.

INTERVIEW Editor | Curator -
Partnered with ATAI Life Sciences ATAI. Amazing Interview. "I said there's no way that you can take one dose of Ibogaine...

Psychedelic Marketing: Adrian Morrison

Uncategorized Editor | Curator -
https://youtu.be/EZPAoTFqaro

Shark Tank’s Kevin Harrington Invests In Psychedelics Company Psycheceutical (BWVI). Forbes

2023 Watch List Editor | Curator -
Mike Zapolin, Kevein Harrington and CEO Chad Harman Another Shark Tank original has invested in the psychedelic industry.

LARGE CAP PSYCHEDELIC STOCKS

PSYCHEDELIC FUNDS AND ETFS

Copyright Revelers,io Media for Instiutional Analyst Inc.